This chapter highlights the failure of FDA oversight in ensuring the safety of over-the-counter eye drops, discussing cases of untested and bacteria-tainted products that caused blindness and deaths. It raises concerns about the inadequacy of FDA requirements and the manufacturing and quality issues in the pharmaceutical industry, particularly in India.
Walter Todd, CIO at Greenwood Capital and Bloomberg Intelligence Senior Global Banks Analyst Alison Williams dig into earnings from Morgan Stanley and Bank of America. Bloomberg News EV Reporter Sean O’Kane and Scott Painter, CEO of Autonomy, talk about how Scott's auto subscription startup has been hampered by Tesla cutting car prices. Tom McGee, President of ICSC, shares his thoughts on June retail sales data and the state of retail stores. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Projects and Investigations Reporter Peter Robison provide the details of Peter's Businessweek Magazine story Untested, Bacteria-Tainted Eyedrops Blinded and Killed Americans. And we Drive to the Close with Mace McCain, Chief Investment Officer at Frost Investment Advisors.
Hosts: Carol Massar and Matt Miller. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.